Adoption of Stereotactic Body Radiotherapy for Stage IA Non-Small Cell Lung Cancer Across the United States.

ABSTRACT:

Background

Stereotactic body radiotherapy (SBRT) is a treatment option for stage I non-small cell lung cancer (NSCLC), providing a potentially curative therapy for patients who are nonsurgical candidates. This study describes the adoption of SBRT vs other treatment options across the United States, as well as commonly used dose-fractionation regimens.

Methods

We analyzed patients in the National Cancer Data Base. A total of 107 233 stage IA NSCLC patients diagnosed from 2008 to 2013 were included. We described the proportions of patients who received different surgical and radiation treatment options by year. A multivariable model was constructed to assess factors associated with patients receiving SBRT. In patients who received SBRT, we described the proportion of patients

SUBMITTER: Holmes JA 

PROVIDER: S-EPMC6649706 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature